Sex Hormones Related Ocular Dryness in Breast Cancer Women

Antonella Grasso, Antonio Di Zazzo, Giuseppe Giannaccare, Jaemyoung Sung, Takenori Inomata, Kendrick Co Shih, Alessandra Micera, Daniele Gaudenzi, Sara Spelta, Maria Angela Romeo, Paolo Orsaria, Marco Coassin (+1 others)
2021 Journal of Clinical Medicine  
Dry eye syndrome (DES) is strictly connected to systemic and topical sex hormones. Breast cancer treatment, the subsequent hormonal therapy, the subsequent hyperandrogenism and the early sudden menopause, may be responsible for ocular surface system failure and its clinical manifestation as dry eye disease. This local dryness is part of the breast cancer iatrogenic dryness, which affects overall mucosal tissue in the fragile population of those with breast cancer. Methods: A literature review
more » ... garding the role of sex hormone changes and systemic hormonal replacement treatments (SHRT) in DES available on PubMed and Web of Science was made without any restriction of language. Results: Androgens exert their role on the ocular surface supporting meibomian gland function and exerting a pro-sebaceous effect. Estrogen seems to show a pro/inflammatory role on the ocular surface, while SHRT effects on dry eye are still not well defined, determining apparently contradictory consequences on the ocular surface homeostasis. The role of sex hormones on dry eye pathogenesis is most likely the result of a strict crosstalk between the protective androgens effects and the androgen-modulating effects of estrogens on the meibomian glands. Conclusions: Patients with a pathological or iatrogenic hormonal imbalance, such as in the case of breast cancer, should be assessed for dry eye disease, as well as systemic dryness, in order to restore their social and personal quality of life.
doi:10.3390/jcm10122620 fatcat:u65y2yua3ffmfef57m7727y6tq